Gri bio announces abstract accepted for poster presentation at the 2024 american thoracic society international conference

La jolla, ca, april 08, 2024 (globe newswire) -- gri bio, inc. (nasdaq: gri) (“gri bio” or the “company”), a biotechnology company advancing an innovative pipeline of natural killer t (nkt) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that its abstract has been accepted for poster presentation at the 2024 ats international conference being held may 17-22, 2024 in san diego, ca.
GRI Ratings Summary
GRI Quant Ranking